169 related articles for article (PubMed ID: 25596283)
1. SND1 Acts Downstream of TGFβ1 and Upstream of Smurf1 to Promote Breast Cancer Metastasis.
Yu L; Liu X; Cui K; Di Y; Xin L; Sun X; Zhang W; Yang X; Wei M; Yao Z; Yang J
Cancer Res; 2015 Apr; 75(7):1275-86. PubMed ID: 25596283
[TBL] [Abstract][Full Text] [Related]
2. SND1 acts as a novel gene transcription activator recognizing the conserved Motif domains of Smad promoters, inducing TGFβ1 response and breast cancer metastasis.
Yu L; Di Y; Xin L; Ren Y; Liu X; Sun X; Zhang W; Yao Z; Yang J
Oncogene; 2017 Jul; 36(27):3903-3914. PubMed ID: 28263968
[TBL] [Abstract][Full Text] [Related]
3. SND1 facilitates the invasion and migration of cervical cancer cells by Smurf1-mediated degradation of FOXA2.
Zhan F; Zhong Y; Qin Y; Li L; Wu W; Yao M
Exp Cell Res; 2020 Mar; 388(1):111809. PubMed ID: 31891682
[TBL] [Abstract][Full Text] [Related]
4. ASPP2 suppresses invasion and TGF-β1-induced epithelial-mesenchymal transition by inhibiting Smad7 degradation mediated by E3 ubiquitin ligase ITCH in gastric cancer.
Gen Y; Yasui K; Kitaichi T; Iwai N; Terasaki K; Dohi O; Hashimoto H; Fukui H; Inada Y; Fukui A; Jo M; Moriguchi M; Nishikawa T; Umemura A; Yamaguchi K; Konishi H; Naito Y; Itoh Y
Cancer Lett; 2017 Jul; 398():52-61. PubMed ID: 28400336
[TBL] [Abstract][Full Text] [Related]
5. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
6. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
[TBL] [Abstract][Full Text] [Related]
7. Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling.
Chen J; Mitra A; Li S; Song S; Nguyen BN; Chen JS; Shin JH; Gough NR; Lin P; Obias V; He AR; Yao Z; Malta TM; Noushmehr H; Latham PS; Su X; Rashid A; Mishra B; Wu RC; Mishra L
Cancer Res; 2020 May; 80(9):1819-1832. PubMed ID: 32127355
[TBL] [Abstract][Full Text] [Related]
8. SMURF1 plays a role in EGF-induced breast cancer cell migration and invasion.
Kwon A; Lee HL; Woo KM; Ryoo HM; Baek JH
Mol Cells; 2013 Dec; 36(6):548-55. PubMed ID: 24241683
[TBL] [Abstract][Full Text] [Related]
9. SMAD specific E3 ubiquitin protein ligase 1 promotes ovarian cancer cell migration and invasion via the activation of the RhoA/ROCK signaling pathway.
Wang W; Du H; Liu H; Hu F; Liu G
Oncol Rep; 2019 Jan; 41(1):668-676. PubMed ID: 30542716
[TBL] [Abstract][Full Text] [Related]
10. HOXB7, a homeodomain protein, is overexpressed in breast cancer and confers epithelial-mesenchymal transition.
Wu X; Chen H; Parker B; Rubin E; Zhu T; Lee JS; Argani P; Sukumar S
Cancer Res; 2006 Oct; 66(19):9527-34. PubMed ID: 17018609
[TBL] [Abstract][Full Text] [Related]
11. SND1 expression in breast cancer tumors is associated with poor prognosis.
Gu X; Xue J; Ai L; Sun L; Zhu X; Wang Y; Liu C
Ann N Y Acad Sci; 2018 Dec; 1433(1):53-60. PubMed ID: 30216461
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
13. RASSF1A Directly Antagonizes RhoA Activity through the Assembly of a Smurf1-Mediated Destruction Complex to Suppress Tumorigenesis.
Lee MG; Jeong SI; Ko KP; Park SK; Ryu BK; Kim IY; Kim JK; Chi SG
Cancer Res; 2016 Apr; 76(7):1847-59. PubMed ID: 26825171
[TBL] [Abstract][Full Text] [Related]
14. A novel mechanism of TGFbeta-induced actin reorganization mediated by Smad proteins and Rho GTPases.
Vardouli L; Vasilaki E; Papadimitriou E; Kardassis D; Stournaras C
FEBS J; 2008 Aug; 275(16):4074-87. PubMed ID: 18631173
[TBL] [Abstract][Full Text] [Related]
15. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
Lei R; Tang J; Zhuang X; Deng R; Li G; Yu J; Liang Y; Xiao J; Wang HY; Yang Q; Hu G
Oncogene; 2014 Mar; 33(10):1287-96. PubMed ID: 23474751
[TBL] [Abstract][Full Text] [Related]
16. Disruption of SND1-MTDH Interaction by a High Affinity Peptide Results in SND1 Degradation and Cytotoxicity to Breast Cancer Cells
Li P; He Y; Chen T; Choy KY; Chow TS; Wong ILK; Yang X; Sun W; Su X; Chan TH; Chow LMC
Mol Cancer Ther; 2021 Jan; 20(1):76-84. PubMed ID: 33268570
[TBL] [Abstract][Full Text] [Related]
17. Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.
Tian F; Byfield SD; Parks WT; Stuelten CH; Nemani D; Zhang YE; Roberts AB
Cancer Res; 2004 Jul; 64(13):4523-30. PubMed ID: 15231662
[TBL] [Abstract][Full Text] [Related]
18. Saponins from the roots of Platycodon grandiflorum suppresses TGFβ1-induced epithelial-mesenchymal transition via repression of PI3K/Akt, ERK1/2 and Smad2/3 pathway in human lung carcinoma A549 cells.
Choi JH; Hwang YP; Kim HG; Khanal T; Do MT; Jin SW; Han HJ; Lee HS; Lee YC; Chung YC; Jeong TC; Jeong HG
Nutr Cancer; 2014; 66(1):140-51. PubMed ID: 24341702
[TBL] [Abstract][Full Text] [Related]
19. Degradation of RhoA by Smurf1 ubiquitin ligase.
Wang HR; Ogunjimi AA; Zhang Y; Ozdamar B; Bose R; Wrana JL
Methods Enzymol; 2006; 406():437-47. PubMed ID: 16472676
[TBL] [Abstract][Full Text] [Related]
20. Novel WWP2 ubiquitin ligase isoforms as potential prognostic markers and molecular targets in cancer.
Soond SM; Smith PG; Wahl L; Swingler TE; Clark IM; Hemmings AM; Chantry A
Biochim Biophys Acta; 2013 Dec; 1832(12):2127-35. PubMed ID: 23938591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
